Lysine-aspirin is a form of aspirin that is administered as a nasal spray. It is used to treat a specific condition called NSAID-exacerbated respiratory disease, which affects both breathing and sinus function. The medication is delivered directly into the nose, which allows it to work locally in the nasal passages and sinuses. This form of treatment is different from regular oral aspirin tablets and is specifically designed for nasal use.

ATAD (Aspirin Treatment After Desensitization) is a therapeutic approach that involves carefully administering aspirin through the nose after the patient has undergone a process to reduce their sensitivity to aspirin. This treatment is used to help manage symptoms in patients who have respiratory problems triggered by aspirin or similar medications.

Nonsteroidal Anti-inflammatory Drug Exacerbated Respiratory Disease (N-ERD) – A chronic medical condition characterized by the combination of asthma, recurring nasal polyps, and respiratory reactions to aspirin and other non-steroidal anti-inflammatory drugs. The condition typically begins with chronic nasal congestion and progresses to include loss of smell, sinus problems, and the development of nasal polyps. Patients experience worsening respiratory symptoms when taking aspirin or similar medications. The condition often involves chronic inflammation of both the upper and lower respiratory tract. The disease usually develops in adulthood and tends to be persistent.